Corporate News     19-Oct-23
KFin Technologies bags multi-year contract from LIC Pension Fund
KFin Technologies has won a high value multi-year contract from LIC Pension Fund (LICPFL) to design, create and administer the investment management solution to provide enhanced customer service, security, compliance, and to be future-ready for the scale LICPFL anticipates achieving.
Previous News
  KFin Tech gains after Q4 PAT climbs 14% YoY to Rs 85 cr
 ( Hot Pursuit - 29-Apr-25   11:08 )
  KFin Technologies invests Rs 19.49 cr in KFin Services
 ( Corporate News - 05-Nov-24   09:39 )
  KFin Technologies allots 1.02 lakh equity shares under ESOP
 ( Corporate News - 07-Sep-23   11:17 )
  KFin Technologies announces cessation of director
 ( Corporate News - 26-May-25   11:39 )
  KFin Technologies incorporates Subsidiary Company
 ( Corporate News - 20-Jun-25   12:56 )
  KFin Techs. to discuss results
 ( Corporate News - 09-Oct-24   10:08 )
  KFin Technologies IPO ends with decent subscription
 ( IPO Centre - IPO News 22-Dec-22   10:35 )
  KFin Technologies allots 50,150 equity shares under ESOP
 ( Corporate News - 11-Jun-24   11:41 )
  KFin Tech takes flight, fueled by Ascent Fund acquisition
 ( Hot Pursuit - 17-Apr-25   12:14 )
  KFin Techs. to announce Quarterly Result
 ( Corporate News - 20-Apr-23   10:18 )
  Torrent Power Ltd leads gainers in 'A' group
 ( Hot Pursuit - 31-Jul-24   12:00 )
Other Stories
  Board of Arkade Developers approves acquisition of Filmistan
  03-Jul-25   11:06
  FAST India partners with Indegene to accelerate biotech innovation in India
  03-Jul-25   11:01
  LMW schedules board meeting
  03-Jul-25   09:15
  Julien Agro Infratech announces board meeting date
  03-Jul-25   09:15
  Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
  03-Jul-25   09:15
  Shriram Asset Mgt. Company schedules AGM
  03-Jul-25   09:14
  Ideaforge Technology to convene AGM
  03-Jul-25   09:14
  D-Link (India) to announce Quarterly Result
  03-Jul-25   09:14
  Tuni Textile Mills to conduct board meeting
  03-Jul-25   09:14
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
  03-Jul-25   09:12
Back Top